COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,221 Articles (22,733 medRxiv, 8,488 bioRxiv)

Most recent first Previous |  Page 573: Articles 5721-5730  | Next

Crystal structure and activity profiling of deubiquitinating inhibitors-bound to SARS-CoV-2 papain like protease revealed new allosteric sites for antiviral therapies
Choudhary, S., Nehul, S., Kumar, K. A., Sharma, S., Rani, R., Saha, A., Sharma, G. K., Tomar, S., Kumar, P.
10.1101/2022.11.11.516107 — Posted: 2022-11-11
Attenuated humoral responses in HIV infection after SARS-CoV-2 vaccination are linked to global B cell defects and cellular immune profiles
Touizer, E., Alrubbayi, A., Ford, R., Hussain, N., Pereyra Gerber, P., Shum, H.-L., Rees-Spear, C., Muir, L., Gea-Mallorqui, E., Kopycinski, J., Jankovic, D., Pinder, C., Fox, T. A., Williams, I., Mullender, C., Maan, I., Waters, L., Johnson, M., Madge, S., Youle, M., Barber, T., Burns, F., Kinloch, S., Rowland-Jones, S., Gilson, R., Matheson, N. J., Morris, E., Peppa, D., McCoy, L. E.
10.1101/2022.11.11.516111 — Posted: 2022-11-11
WHAT IS THE RISK OF DEVELOPING A SEVERE FORM OF COVID-19 INFECTION AMONG ADULTS WHO CURRENTLY SMOKE COMPARED TO EX-SMOKERS? A protocol for systematic review and meta-analysis
Abaate, T. J., Prince, A. N.
10.1101/2022.11.10.22282181 — Posted: 2022-11-11
A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein
Thijssen, V., Hurdiss, D. L., Debski-Antoniak, O. J., Spence, M. A., Franck, C., Norman, A., Aggarwal, A., Mokiem, N. J., van Dongen, D. A. A., Vermeir, S. W., Liu, M., Chatziandreou, M., Donselaar, T., Du, W., Drulyte, I., Bosch, B. J., Snijder, J., Turville, S. G., Payne, R. J., Jackson, C. J., van Kuppeveld, F. J. M., Jongkees, S. A. K.
10.1101/2022.11.11.516114 — Posted: 2022-11-11
Selection of long COVID symptoms influences prevalence estimates in a prospective cohort
Wynberg, E., de Bree, G. J., Leenstra, T., Verveen, A., van Willigen, H. D. G., de Jong, M., Prins, M., Boyd, A., the RECoVERED Study Group
10.1101/2022.11.09.22282120 — Posted: 2022-11-11
Cotranslational formation of disulfides guides folding of the SARS CoV-2 receptor binding domain
Bitran, A., Park, K., Serebryany, E., Shakhnovich, E.
10.1101/2022.11.10.516025 — Posted: 2022-11-11
Health, socioeconomic and genetic predictors of COVID-19 vaccination uptake: a nationwide machine-learning study
Hartonen, T., Jermy, B., Sonajalg, H., Vartiainen, P., Krebs, K., Vabalas, A., FinnGen, , Estonian Biobank research team, , Leino, T., Nohynek, H., Sivela, J., Magi, R., Daly, M. J., Ollila, H. M., Milani, L., Perola, M., Ripatti, S., Ganna, A.
10.1101/2022.11.11.22282213 — Posted: 2022-11-11
Cohort profile: A Quebec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)
Germain, M., Lewin, A., Bazin, R., Dieude, M., Perreault, J., Boivin, A., Gregoire, Y., Renaud, C.
10.1101/2022.11.09.22282156 — Posted: 2022-11-11
Assessing the spatial-temporal risks of SARS-CoV-2 infection for healthcare-workers in the hospital using behavioural indices from routine data
Wilson-Aggarwal, J., Gotts, N., Arnold, K., Spyer, M. J., Houlihan, C., Nastouli, E., Manley, E.
10.1101/2022.11.10.22282176 — Posted: 2022-11-11
A Tale of Two Waves: Diverse Genomic and Transmission Landscapes Over 15 Months of the COVID-19 Pandemic in Pune, India
Niveditha, D., Khan, S., Khilari, A., Nadkarni, S., Bhalerao, U., Kadam, P., Yadav, R., Kanekar, J., Shah, N., Likhitkar, B., Sawant, R., Thakur, S., Tupekar, M., nagar, D., Rao, A., Jagtap, R., Jogi, S., Belekar, M., Pathak, M., Shah, P., Ranade, S., Phadke, N., Das, R., Joshi, S., Karyakarte, R. P., Ghose, A., Kadoo, N., Shashidhara, L., Monteiro, J. M., Shanmugam, D., Raghunathan, A., Karmodiya, K.
10.1101/2022.11.05.22281203 — Posted: 2022-11-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).